These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 32242220)
1. DUX4 expressing immortalized FSHD lymphoblastoid cells express genes elevated in FSHD muscle biopsies, correlating with the early stages of inflammation. Banerji CRS; Panamarova M; Zammit PS Hum Mol Genet; 2020 Aug; 29(14):2285-2299. PubMed ID: 32242220 [TBL] [Abstract][Full Text] [Related]
2. PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level. Banerji CRS; Zammit PS Hum Mol Genet; 2019 Jul; 28(13):2224-2236. PubMed ID: 31067297 [TBL] [Abstract][Full Text] [Related]
3. MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD. Wang LH; Friedman SD; Shaw D; Snider L; Wong CJ; Budech CB; Poliachik SL; Gove NE; Lewis LM; Campbell AE; Lemmers RJFL; Maarel SM; Tapscott SJ; Tawil RN Hum Mol Genet; 2019 Feb; 28(3):476-486. PubMed ID: 30312408 [TBL] [Abstract][Full Text] [Related]
4. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers. van den Heuvel A; Lassche S; Mul K; Greco A; San León Granado D; Heerschap A; Küsters B; Tapscott SJ; Voermans NC; van Engelen BGM; van der Maarel SM Sci Rep; 2022 Jan; 12(1):1426. PubMed ID: 35082321 [TBL] [Abstract][Full Text] [Related]
5. PAX7 target gene repression associates with FSHD progression and pathology over 1 year. Banerji CRS Hum Mol Genet; 2020 Aug; 29(13):2124-2133. PubMed ID: 32347924 [TBL] [Abstract][Full Text] [Related]
6. PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle. Banerji CRS; Panamarova M; Hebaishi H; White RB; Relaix F; Severini S; Zammit PS Nat Commun; 2017 Dec; 8(1):2152. PubMed ID: 29255294 [TBL] [Abstract][Full Text] [Related]
7. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. Snider L; Geng LN; Lemmers RJ; Kyba M; Ware CB; Nelson AM; Tawil R; Filippova GN; van der Maarel SM; Tapscott SJ; Miller DG PLoS Genet; 2010 Oct; 6(10):e1001181. PubMed ID: 21060811 [TBL] [Abstract][Full Text] [Related]
8. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Yao Z; Snider L; Balog J; Lemmers RJ; Van Der Maarel SM; Tawil R; Tapscott SJ Hum Mol Genet; 2014 Oct; 23(20):5342-52. PubMed ID: 24861551 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies. Wong CJ; Wang LH; Friedman SD; Shaw D; Campbell AE; Budech CB; Lewis LM; Lemmers RJFL; Statland JM; van der Maarel SM; Tawil RN; Tapscott SJ Hum Mol Genet; 2020 Apr; 29(6):1030-1043. PubMed ID: 32083293 [TBL] [Abstract][Full Text] [Related]
10. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Jones TI; Chen JC; Rahimov F; Homma S; Arashiro P; Beermann ML; King OD; Miller JB; Kunkel LM; Emerson CP; Wagner KR; Jones PL Hum Mol Genet; 2012 Oct; 21(20):4419-30. PubMed ID: 22798623 [TBL] [Abstract][Full Text] [Related]
11. Direct interplay between two candidate genes in FSHD muscular dystrophy. Ferri G; Huichalaf CH; Caccia R; Gabellini D Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393 [TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA sequencing in facioscapulohumeral muscular dystrophy disease etiology and development. van den Heuvel A; Mahfouz A; Kloet SL; Balog J; van Engelen BGM; Tawil R; Tapscott SJ; van der Maarel SM Hum Mol Genet; 2019 Apr; 28(7):1064-1075. PubMed ID: 30445587 [TBL] [Abstract][Full Text] [Related]
13. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity. Jones TI; Chew GL; Barraza-Flores P; Schreier S; Ramirez M; Wuebbles RD; Burkin DJ; Bradley RK; Jones PL Skelet Muscle; 2020 Apr; 10(1):8. PubMed ID: 32278354 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei. Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560 [TBL] [Abstract][Full Text] [Related]
15. A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4. Sasaki-Honda M; Jonouchi T; Arai M; Hotta A; Mitsuhashi S; Nishino I; Matsuda R; Sakurai H Hum Mol Genet; 2018 Dec; 27(23):4024-4035. PubMed ID: 30107443 [TBL] [Abstract][Full Text] [Related]
16. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients. Dmitriev P; Bou Saada Y; Dib C; Ansseau E; Barat A; Hamade A; Dessen P; Robert T; Lazar V; Louzada RAN; Dupuy C; Zakharova V; Carnac G; Lipinski M; Vassetzky YS Free Radic Biol Med; 2016 Oct; 99():244-258. PubMed ID: 27519269 [TBL] [Abstract][Full Text] [Related]
17. Gene expression during normal and FSHD myogenesis. Tsumagari K; Chang SC; Lacey M; Baribault C; Chittur SV; Sowden J; Tawil R; Crawford GE; Ehrlich M BMC Med Genomics; 2011 Sep; 4():67. PubMed ID: 21951698 [TBL] [Abstract][Full Text] [Related]